Skip to content
Healthcare
KZActiveBIN 040440032128
Plans from 2 000 ₸ a month
1/17
High risk
Not present at its registered address
To risks

ТОО "НАУЧНЫЙ ЦЕНТР ЗДОРОВЬЯ И ДОЛГОЛЕТИЯ"

Director
Асенбек Ханымгүл
Incorporated
07.04.2004
Address
Алматы УЛ РАДОСТОВЦА, 152/6
РНН
600400531079

This is a company preview

Unlock the full report for 1 check — contacts, bank accounts, court cases, government contracts, arrests, licenses and PDF export.

The pack is not a subscription, its checks last 30 days

Risks

1/17
Not present at its registered addressHigh risk

Комитет государственных доходов · data as of 14.01.2026

This assessment is informational and analytical only, based on our internal methodology and open sources; it is not an official government conclusion or a guarantee of reliability.

Procurement signals

Court cases

Arrests & encumbrances

Enforcement proceedings

Certificates

Licenses

Profile

Summary

Full name
ТОВАРИЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "НАУЧНЫЙ ЦЕНТР ЗДОРОВЬЯ И ДОЛГОЛЕТИЯ"
BIN
040440032128
Status
Active
Director
Асенбек Ханымгүл
Registration date
07.04.2004
Activity
Прочая деятельность в области здравоохранения, не включенная в другие группировки
Legal address
Алматы УЛ РАДОСТОВЦА, 152/6
VAT payer
No
КАТО
751410000
РНН
600400531079
КФС
Собственность предприятий без государственного и иностранного участия
КСЕ
Национальные частные нефинансовые корпорации – ОПП
Company size
Малые предприятия
Employees
от 0 до 5 чел.
Procurement role
Поставщик

Activities

3
86909primary

Прочая деятельность в области здравоохранения, не включенная в другие группировки

Secondary

  • 85410Послесреднее образование
  • 85609Прочая вспомогательная деятельность в области образования
Download

Contacts

Change history

Financials

Tax payments

6

By year · ₸

2026
948.1K
2025
1.8M+167%
2024
672.6K+51%
2023
445.1K+5%
2022
422.2K+1466%
2021
27K
·948.1K
2026year to date
+167%1.8M
2025
+51%672.6K
2024
+5%445.1K
2023
+1466%422.2K
2022
·27K
2021
2026
Tax paid948,100 ₸
Penalty0 ₸
Fine0 ₸
VAT refund0 ₸
2025
Tax paid1,796,415 ₸
Penalty14,350 ₸
Fine0 ₸
VAT refund0 ₸
2024
Tax paid672,562 ₸
Penalty0 ₸
Fine0 ₸
VAT refund0 ₸
2023
Tax paid445,100 ₸
Penalty0 ₸
Fine0 ₸
VAT refund0 ₸
2022
Tax paid422,151 ₸
Penalty21 ₸
Fine0 ₸
VAT refund0 ₸
2021
Tax paid26,950 ₸
Penalty0 ₸
Fine0 ₸
VAT refund0 ₸
Estimated taxable profit

Estimate: corporate income tax ÷ 0%. Not a filing and not revenue — the taxable profit implied by the corporate income tax paid. Actual profit differs by deductions, carried-forward losses and reduced rates.

Download

Financial statements

Premium

Public contracts

What it sells and where

Samruk-Kazyna procurement

Tender bids

Procurement as a customer

Assets

Bank accounts

Management & owners

Leadership

1
  • АХ

    Асенбек Ханымгүл

    Director

Download

Founders

Accreditations

Employees

Affiliated companies

Premium

Director's involvement in other legal entities

Branches

Relations & mentions

Company networks

Premium

Similar companies

Media mentions

Company summary

ТОО "НАУЧНЫЙ ЦЕНТР ЗДОРОВЬЯ И ДОЛГОЛЕТИЯ" (BIN 040440032128) is an active legal entity in Алматы, registered in 2004 (22 years on the market). Primary activity — прочая деятельность в области здравоохранения, не включенная в другие группировки. Per open government registries as of November 7, 2026: 4 government contracts on Портал государственных закупок РК (goszakup.gov.kz) worth 4,214,000 ₸. Automated screening found 1 risk indicator for "НАУЧНЫЙ ЦЕНТР ЗДОРОВЬЯ И ДОЛГОЛЕТИЯ". Director on record — Асенбек Ханымгүл. Data current as of November 7, 2026.

Information is aggregated from open government registries of Kazakhstan: Министерство юстиции РК, Комитет государственных доходов МФ РК, Верховный Суд РК, Портал государственных закупок РК, АО «Самрук-Казына», Бюро национальной статистики РК, Портал электронного лицензирования. Data is indexed automatically and may lag behind primary sources; the absence of a record does not guarantee the absence of the corresponding facts. This is reference information and does not replace an official extract. Learn more about the methodology and sources — SafeDeal editorial policy.